Modified virus injected into tumors to fight advanced cancers
NCT ID NCT07128914
Summary
This is an early-stage study testing the safety of a new treatment called GO306, a genetically modified virus designed to infect and kill cancer cells. It is being given as an injection directly into tumors or into body cavities for adults with advanced solid tumors that have not responded to standard therapies. The main goals are to find a safe dose and see if the treatment shows any early signs of helping to control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fujian Cancer Hospital
RECRUITINGFuzhou, Fujian, China
Contact
-
Hunan Cancer Hospital
RECRUITINGChangsha, Hunan, China
Contact
-
Shanghai General Hospital
RECRUITINGShanghai, Shanghai Municipality, 201620, China
Contact
Contact
-
Shenzhen Third People's Hospital
RECRUITINGShenzhen, Guangzhou, 518112, China
Contact
-
The First Affiliated Hospital of Anhui Medical University
RECRUITINGHefei, Anhui, China
Contact
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, Henan, China
Contact
Conditions
Explore the condition pages connected to this study.